Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement

Open access
Bousquet, Jean, Akdis, Cezmi A., Jutel, Marek, Bachert, Claus, Klimek, Ludger, Agache, Ioana, Ansotegui, Ignacio J., Bedbrook, Anna, Bosnic‐Anticevich, Sinthia, Canonica, G. Walter, Chivato, Tomas, Cruz, Alvaro A., Czarlewski, Wienczyslawa, Del Giacco, Stefano, Du, Hui, Fonseca, Joao A., Gao, Yadong, Haahtela, Tari, Hoffmann‐Sommergruber, Karin, Ivancevich, Juan‐Carlos, Khaltaev, Nikolaï, Knol, Edward F., Kuna, Piotr, Larenas‐Linnemann, Desiree, Mullol, Joaquim, Naclerio, Robert, Ohta, Ken, Okamoto, Yoshitaka, O’Mahony, Liam, Onorato, Gabrielle L., Papadopoulos, Nikos G., Pfaar, Oliver, Samolinski, Boleslaw, Schwarze, Jürgen, Toppila‐Salmi, Sanna, Ventura, Maria-Teresa, Valiulis, Arunas, Yorgancioglu, Arzu, Zuberbier, Torsten, Pawankar, Ruby, the ARIA‐MASK Study Group·2020·Allergy

Abstract

A novel strain of human coronaviruses, named by the International Committee on Taxonomy of Viruses (ICTV) 1 as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged and caused an infectious disease. This disease has recently been referred to by the World Health Organisation (WHO) as the "coronavirus disease 2019" (COVID-19). Since the first report of this disease in December 2019 in Wuhan, China, 2,3 COVID-19 has aggressively spread across the globe. WHO declared it a pandemic on March 11. COVID-19 presents with many different clinical manifestations, ranging from asymptomatic cases to mild and severe disease, with or without pneumonia. 4 Patients with common allergic conditions do not develop additional distinct symptoms and do not seem to be at an increased risk of severe disease. Allergic children show a mild course, like other children. 5 COVID-19 cases with pre-existing COPD, or complicated by secondary bacterial pneumonia, are more severe, and this may be due to a complex immune pathogenesis. Whether systemic corticosteroids have a deleterious effect on COVID-19 infection is still a matter of discussion. Clinical evidence does not support corticosteroid treatment for SARS-CoV-2 pneumonia. 6 Moreover, corticosteroid therapy in patients with MERS (Middle East respiratory syndrome) was not associated with a difference in mortality after adjustment for time-varying confounders but was associated with delayed MERS coronavirus RNA clearance. 7

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.14302

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 161

Metadata

Authors
Bousquet, J., Akdis, C. A., Jutel, M., Bachert, C., Klimek, L., Agache, I., Ansotegui, I. J., Bedbrook, A., Bosnic‐Anticevich, S., Canonica, G. W., Chivato, T., Cruz, A. A., Czarlewski, W., Del Giacco, S., Du, H., Fonseca, J. A., Gao, Y., Haahtela, T., Hoffmann‐Sommergruber, K., Ivancevich, J., Khaltaev, N., Knol, E. F., Kuna, P., Larenas‐Linnemann, D., Mullol, J., Naclerio, R., Ohta, K., Okamoto, Y., O’Mahony, L., Onorato, G. L., Papadopoulos, N. G., Pfaar, O., Samolinski, B., Schwarze, J., Toppila‐Salmi, S., Ventura, M.-T., Valiulis, A., Yorgancioglu, A., Zuberbier, T., Pawankar, R., & the ARIA‐MASK Study Group
Venue
Allergy
Publisher
Wiley
Published
2020-10
Volume
75
Issue
10
Pages
2440-2444
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W3013494042
Cited by
161
References
1
FWCI
22.78
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement. https://app.cochat.ai/papers/10.1111/all.14302
The paper
Bousquet, J., Akdis, C. A., Jutel, M., Bachert, C., Klimek, L., Agache, I., Ansotegui, I. J., Bedbrook, A., Bosnic‐Anticevich, S., Canonica, G. W., Chivato, T., Cruz, A. A., Czarlewski, W., Del Giacco, S., Du, H., Fonseca, J. A., Gao, Y., Haahtela, T., Hoffmann‐Sommergruber, K., . . . the ARIA‐MASK Study Group. (2020). Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement. Allergy. https://doi.org/10.1111/all.14302

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.